| Literature DB >> 27145264 |
Yao Liu1,2,3, Xiaoxing Kou3,4, Chider Chen3,4, Wenjing Yu3,4, Yingying Su5, Yong Kim6, Songtao Shi3,4, Yi Liu5.
Abstract
Chronic consumption of excessive alcohol results in reduced bone mass, impaired bone structure, and increased risk of bone fracture. However, the mechanisms underlying alcohol-induced osteoporosis are not fully understood. Here, we show that high dose chronic alcohol consumption reduces osteogenic differentiation and enhances adipogenic differentiation of bone marrow mesenchymal stem cells (BMMSCs), leading to osteopenia in a mouse model. Mechanistically, impaired osteo/adipogenic lineage differentiation of BMMSCs is due to activation of a phosphatidylinositide 3-kinase/AKT/mammalian target of rapamycin (mTOR) signaling cascade, resulting in downregulation of runt-related transcription factor 2 and upregulation of peroxisome proliferator-activated receptor gamma via activation of p70 ribosomal protein S6 kinase. Blockage of the mTOR pathway by rapamycin treatment ameliorates alcohol-induced osteopenia by rescuing impaired osteo/adipogenic lineage differentiation of BMMSCs. In this study, we identify a previously unknown mechanism by which alcohol impairs BMMSC lineage differentiation and reveal a potential rapamycin-based drug therapy for alcohol-induced osteoporosis. Stem Cells 2016;34:2157-2168.Entities:
Keywords: Adipogenesis; Alcohol consumption; Bone marrow mesenchymal stem cells; Osteogenesis; Osteoporosis; Rapamycin
Mesh:
Substances:
Year: 2016 PMID: 27145264 DOI: 10.1002/stem.2392
Source DB: PubMed Journal: Stem Cells ISSN: 1066-5099 Impact factor: 6.277